Cargando…
Biotechnologically Engineered Plants
SIMPLE SUMMARY: Scientists are exploring the use of new genetic tools to engineer crop varieties which can result in desirable traits such as improved yield, disease resistance, and enhanced nutritional value. By manipulating the plants’ genetic makeup, they are able to develop transgenic plants cap...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135915/ https://www.ncbi.nlm.nih.gov/pubmed/37106801 http://dx.doi.org/10.3390/biology12040601 |
_version_ | 1785032094555045888 |
---|---|
author | Narayanan, Zareen Glick, Bernard R. |
author_facet | Narayanan, Zareen Glick, Bernard R. |
author_sort | Narayanan, Zareen |
collection | PubMed |
description | SIMPLE SUMMARY: Scientists are exploring the use of new genetic tools to engineer crop varieties which can result in desirable traits such as improved yield, disease resistance, and enhanced nutritional value. By manipulating the plants’ genetic makeup, they are able to develop transgenic plants capable of producing valuable biotechnological compounds. The development of plant-based biomanufacturing could offer a more sustainable and cost-effective method to produce useful products compared to traditional manufacturing process. ABSTRACT: The development of recombinant DNA technology during the past thirty years has enabled scientists to isolate, characterize, and manipulate a myriad of different animal, bacterial, and plant genes. This has, in turn, led to the commercialization of hundreds of useful products that have significantly improved human health and well-being. Commercially, these products have been mostly produced in bacterial, fungal, or animal cells grown in culture. More recently, scientists have begun to develop a wide range of transgenic plants that produce numerous useful compounds. The perceived advantage of producing foreign compounds in plants is that compared to other methods of producing these compounds, plants seemingly provide a much less expensive means of production. A few plant-produced compounds are already commercially available; however, many more are in the production pipeline. |
format | Online Article Text |
id | pubmed-10135915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101359152023-04-28 Biotechnologically Engineered Plants Narayanan, Zareen Glick, Bernard R. Biology (Basel) Review SIMPLE SUMMARY: Scientists are exploring the use of new genetic tools to engineer crop varieties which can result in desirable traits such as improved yield, disease resistance, and enhanced nutritional value. By manipulating the plants’ genetic makeup, they are able to develop transgenic plants capable of producing valuable biotechnological compounds. The development of plant-based biomanufacturing could offer a more sustainable and cost-effective method to produce useful products compared to traditional manufacturing process. ABSTRACT: The development of recombinant DNA technology during the past thirty years has enabled scientists to isolate, characterize, and manipulate a myriad of different animal, bacterial, and plant genes. This has, in turn, led to the commercialization of hundreds of useful products that have significantly improved human health and well-being. Commercially, these products have been mostly produced in bacterial, fungal, or animal cells grown in culture. More recently, scientists have begun to develop a wide range of transgenic plants that produce numerous useful compounds. The perceived advantage of producing foreign compounds in plants is that compared to other methods of producing these compounds, plants seemingly provide a much less expensive means of production. A few plant-produced compounds are already commercially available; however, many more are in the production pipeline. MDPI 2023-04-15 /pmc/articles/PMC10135915/ /pubmed/37106801 http://dx.doi.org/10.3390/biology12040601 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Narayanan, Zareen Glick, Bernard R. Biotechnologically Engineered Plants |
title | Biotechnologically Engineered Plants |
title_full | Biotechnologically Engineered Plants |
title_fullStr | Biotechnologically Engineered Plants |
title_full_unstemmed | Biotechnologically Engineered Plants |
title_short | Biotechnologically Engineered Plants |
title_sort | biotechnologically engineered plants |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135915/ https://www.ncbi.nlm.nih.gov/pubmed/37106801 http://dx.doi.org/10.3390/biology12040601 |
work_keys_str_mv | AT narayananzareen biotechnologicallyengineeredplants AT glickbernardr biotechnologicallyengineeredplants |